The oligometastatic status of non-small lung cancer (NSCLC) has been extensively studied over the years owing to its potential significance in long-term survival.
Bone is one of the most commonly affected organs in oligometastatic NSCLC.
The value of comprehensive local therapy (CLT) for NSCLC with solitary skeletal oligometastasis remains to be established.
